Biparatopic antibodies: therapeutic applications and prospects-Reference-Cited by-同舟云学术

Biparatopic antibodies: therapeutic applications and prospects

Published:2024-03-04 Issue:1 Volume:16 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Niquille David L.¹^ORCID,Fitzgerald Kyle M.¹^ORCID,Gera Nimish¹^ORCID

Affiliation:

1. Biologics, Mythic Therapeutics, Waltham, MA, USA

Funder

no funding associated with the work

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2024.2310890

Reference89 articles.

1. U.S. Food & Drug Administration Center for Drug Evaluation and Research. Advancing health through innovation: new drug therapy approvals 2022. Silver Spring Maryland. 2023. Accessed 2023 Jul 24. https://www.fda.gov/media/164429/download?attachment.

2. Antibodies to watch in 2023

3. Affinity enhancement of bispecific antibody against two different epitopes in the same antigen

4. Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities

5. The evolution of bispecific antibodies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2–/ERBB2-Altered Advanced Biliary Tract Cancers;Journal of Clinical Oncology;2024-08-05

2. Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule;2024-08-03

3. Therapeutic potential of cis-targeting bispecific antibodies;Cell Chemical Biology;2024-08

4. Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer;International Journal of Clinical Oncology;2024-07-31

5. A Biparatopic Intrabody Renders Vero Cells Impervious to Ricin Intoxication;2024-07-03